Trial intelligence / Profile preview

GLP-1 Agonism for Browning of Subcutaneous White Adipose Tissue in Obesity

NCT02170324Phase 4Completed

Start
Jun 2014
Primary completion
Jul 2015
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of exenatide in obesity. Started Jun 2014; status: completed.

02

Drugs

exenatide
03

Conditions

obesity

Beyond the preview

Go deeper on NCT02170324.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02170324.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call